Shares of Genetron Holdings Limited (NASDAQ:GTH) traded at a new 52-week high today of $29.91. So far today approximately 168,000 shares have been exchanged, as compared to an average 30-day volume of 481,000 shares.
Based on a current price of $29.91, Genetron Holdings Limited is currently 94.4% above its average consensus analyst price target of $1.68.
In the past 52 weeks, Genetron Holdings Limited share prices are bracketed by a low of $9.03 and a high of $29.91 and is now at $29.91, 231% above that low price.
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company generates revenue through precision oncology testing and development services. Precision oncology testing includes the diagnosis and monitoring and early screening performed in the form of LDT services and IVD products. Development services consist of research services and sequencing services.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer